NCT04604262

Brief Summary

There is no long term evidence to show that the use of Waterpik® is effective for orthodontic patients with fixed braces. A Cochrane Systematic Review confirms this. The aims of this study is to find out if the use of Waterpik® in addition to the manual toothbrush is better to maintain clean teeth in patients with fixed braces. The null hypothesis is that there is no difference between patients using either Waterpik® in addition to the manual toothbrush (treatment group) when compared with patients using just the manual toothbrush (control group).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2019

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

October 9, 2020

Completed
18 days until next milestone

First Posted

Study publicly available on registry

October 27, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 26, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 26, 2021

Completed
Last Updated

February 24, 2022

Status Verified

February 1, 2022

Enrollment Period

2.2 years

First QC Date

October 9, 2020

Last Update Submit

February 7, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in Plaque index from baseline

    The patient will be disclosed by the clinical investigator who will be blind to the toothbrush group allocation. The disclosed mouth will be photographed and plaque scored at the same time. The photograph will allow for a re-score and to check the validity of the clinical score. Plaque will be assessed on the buccal surfaces of the teeth on which orthodontic brackets has been placed using the orthodontic modification of the Silness and Loe plaque index. This index has been shown to be sensitive in detecting differences in plaque levels in orthodontic patients with fixed braces. This index divides the tooth surface into four zones in relation to the orthodontic bracket: incisal, distal, mesial and cervical and codes 0-3 were assigned.

    8, 32, 56 weeks

  • Change in Gingivitis from baseline

    Gingivitis will be measured on the buccal surfaces of the teeth with the gingival index using a CPITN probe.

    8, 32, 56 weeks

  • Change in Gingival bleeding from baseline

    Gingival bleeding will be determined using the Eastman interdental bleeding index. This will involve inserting a wooden interdental cleaner (Interdental woodsticks, Oral-B Laboratories, Aylesbury, UK) between the teeth from the buccal aspect and depressing the interdental papilla by 1-2 mm. The presence or absence of marginal interdental bleeding from the papilla within 15 seconds will be recorded. The Eastman interdental bleeding index is the number of bleeding sites as expressed as a percentage of the total sites evaluated.

    8, 32, 56 weeks

Study Arms (2)

Treatment Group

EXPERIMENTAL

Waterpik® in addition to the manual toothbrush

Device: Waterpik

Control

NO INTERVENTION

Manual toothbrush

Interventions

WaterpikDEVICE

Waterpik dental water jet

Treatment Group

Eligibility Criteria

Age8 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
1. All patients will have a dental history that included brushing at least twice a day and be willing and able to comply with the trial regime. They will also be between 10 and 20 years of age and in good general health. Any patients with medical conditions and those necessitating chemotherapy which may alter the oral tissue's response to fixed appliance treatment will be excluded. Examples include heart conditions requiring antibiotic cover, diabetes mellitus, immunosuppressant drugs, antibiotics, steroids and hormonal therapy. 2. Patients with decreased manual dexterity either due to mental or physical disabilities and poor compliance will be excluded. Patients with poor initial periodontal health will also be excluded. 3. All medications which may alter plaque accumulation should be avoided during the trial period, but if required on professional advice should report this to the clinical investigator. 4. All patients will have brackets as opposed to bands except permanent molar teeth which may be banded. 5. The patients will have full upper and lower arch treatment as oppose to sectional arch treatment. This is so that the difficulties involved in cleaning all the teeth are similar. 6. They should be bonded using one single type of cement, as we are unsure if different types of cement would influence the accumulation of plaque. This may be true with glass ionomer cement, as it has been shown to inhibit growth of some bacteria. The cement chosen for this purpose is Transbond XT® by 3M Unitek as this the cement most familiar to the operator. Furthermore any breakages from the appliances will be repaired using this cement. This will also ensure that consistent cement will be used. 7. The fixed braces will be of the pre-adjusted Edgewise type as auxiliaries used in other appliance type may pose to be confounding factor. As this unit uses the AO Orthodontics, MBT prescription brackets, this will be the brackets used for this trial. 8. Patients who already use any other supplements to the manual toothbrush for their oral hygiene will be excluded so as not to disadvantage their oral hygiene during their trial

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

York Teaching Hospital NHS Foundation Trust

York, North Yorkshire, YO31 8HE, United Kingdom

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Independent outcome assessors
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This will be a 56-week single blind, stratified; parallel group randomised controlled clinical trial. This will be a pseudo-longitudinal trial where observations are recorded at certain fixed intervals.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 9, 2020

First Posted

October 27, 2020

Study Start

September 1, 2019

Primary Completion

November 26, 2021

Study Completion

November 26, 2021

Last Updated

February 24, 2022

Record last verified: 2022-02

Locations